Wire Stories

WNS-Denali & CIPS Collaborate to Identify Attributes of High-Performance Procurement

BELLEVUE, Wash.--(BUSINESS WIRE)--#AlparKamber--WNS-Denali, an established leader in global sourcing and procurement solutions, has released a Benchmark Study on procurement performance…

6 years ago

Highway Holdings Appoints New Directors

Highlights Company’s Efficiency and Competitive Position HONG KONG--(BUSINESS WIRE)--Highway Holdings Limited (Nasdaq:HIHO) today announced its board of directors has appointed…

6 years ago

FRANKFURT, Germany--(BUSINESS WIRE)--#americafirst--Robots play an important role in fighting the coronavirus SARS-CoV-2 around the globe. Disinfection robot UVD for example…

6 years ago

Connected Consumer Survey 2019 – TV & Video Services in Australia & New Zealand – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "The Connected Consumer Survey 2019: TV and Video Services in Australia and New Zealand" report has been added…

6 years ago

Kurita Water Industries Announces Merger of Its U.S. Subsidiaries

Newly formed Kurita America aims to change how water treatment solutions are designed and delivered NAKANO-KU, Japan--(BUSINESS WIRE)--Kurita Water Industries,…

6 years ago

MUFG Appoints New Members to Global Advisory Board

TOKYO--(BUSINESS WIRE)--MUFG is pleased to announce today the appointment of two new members to its Global Advisory Board: Ms. Anne…

6 years ago

MetLife Foundation Commits $25 Million to Global COVID-19 Response

HONG KONG--(BUSINESS WIRE)--MetLife Foundation yesterday announced that it is committing $25 million to the global response to COVID-19 in support…

6 years ago

KKR Appoints Hidekazu Harada as Managing Director in Japan

TOKYO--(BUSINESS WIRE)--KKR, a leading global investment firm, today announced the appointment of Hidekazu Harada as a Managing Director on KKR’s…

6 years ago

Modalis Obtains Access to Foundational CRISPR IP

Modalis Therapeutics and Editas Medicine conclude license TOKYO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--#CRISPR--Modalis Therapeutics Corporation (Modalis) today announced that the company…

6 years ago

Notice Regarding Business Alliance Between Sanbio and Ocumension in the Research, Development and Commercialization of Innovative Stem Cell Therapies for Ophthalmic Diseases

TOKYO--(BUSINESS WIRE)--SanBio Co., Ltd. (Keita Mori, Representative Director and President, hereinafter “SanBio”) (TOKYO:4592) hereby announces that SanBio has entered into…

6 years ago